1 / 19

Automated Software Framework for Voxelized Absorbed Dose Estimation in Radionuclide Therapy

P Jackson, PhD; J Beauregard, MD, MSc; T Kron, PhD, DIPLPHYS; M S Hofman, MBBS; R Hicks, MBBS price.jackson@petermac.org Centre for Molecular Imaging Peter MacCallum Cancer Centre East Melbourne, Australia.

remedy
Download Presentation

Automated Software Framework for Voxelized Absorbed Dose Estimation in Radionuclide Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. P Jackson, PhD; J Beauregard, MD, MSc; T Kron, PhD, DIPLPHYS; M S Hofman, MBBS; R Hicks, MBBS price.jackson@petermac.org Centre for Molecular Imaging Peter MacCallum Cancer Centre East Melbourne, Australia Automated Software Framework for Voxelized Absorbed Dose Estimation in Radionuclide Therapy

  2. Purpose: • Accurately map distribution of radiation dose to healthy & target tissues in Peptide Receptor Radionuclide Therapy (PRRT) • Treatment given over 4 or more cycles • Opportunity to adjust prescription based on absorbed dose estimate? Small volume disease, limited absorption in lesion, high SUV in kidneys & spleen Bulky & highly octreotate-avid liver lesions, limited uptake observed in healthy organs

  3. Internal Emitter Dosimetry • Radionuclide Dosimetry as function of: • Pharmacokinetics • Biological half-life, uptake & clearance (multiple phases) • Physical half-life • Emission particles • Type & energy • Absorbing medium • Generally soft-tissue (high-dose regions) • MIRD: OLINDA/EXM (Gold Standard) • Male/Female/child MIRD phantoms with customizable organ mass • Absorbed dose values accurate when considered over large population • Difficult to account for absorbed dose to tumour/target volume • Not intended for individualised dosimetry “NOTE: This code gives doses for stylized models of average individuals - results should be applied with caution to specific subjects.” Not an issue for short-range beta emitters, though • Significant Manual input • No accounting for sub-organ kinetics (renal pelvis vs. cortex)

  4. Image Registration 4-Hour Fused SPECT/CT 24-Hour Fused SPECT/CT 72-Hour Fused SPECT/CT 4-Hour CT Fused to Cumulated Activity Image (Bq*Hr/mL) 4-Hour CT Fused to Absorbed Dose Image (mGy) Voxel S-Value & Gamma Convolution Kernel 4-Hour CT Fused to 4-, 24- & 72-hour SPECT Voxelized Kinetics Curve Fitting parameters per voxel Video: Interpolated activity & Cumulated activity Visual Analysis Voxelized Registration and Kinetics (VRAK) • In-house dosimetry protocol based on serial SPECT/CT: • Deformable Registration • Automatic Kinetics fitting & activity integration • Voxel S-Values (EGSnrc) • Output: dicom dose & cumulated activity volumes, data file with per voxel kinetics parameters • All scripted • Called from command-line w/text input file • Python-based (pydicom, numpy) • Open-source dependencies • Cross-platform (Win, Mac, Unix)

  5. Quantitative SPECT CT: • 177Lu: 112 keV (6.2%) & 208.4 keV (10.4%) γ’s, 497 keVmax β- (100%) • 3 Quantitative SPECT/CT series • 4, 24, 72 hours Post-injection • SPECT quantitation previously calibrated* • 177Lu-specific attenuation & dead-time correction • 2 couch position (chest+abdomen) • Full datasets for 28 LuTate Rx’s (18 different patients) used for validation *Beauregard, J.-M. et al., 2011. Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system. Cancer imaging: the official publication of the International Cancer Imaging Society, 11, pp.56-66.

  6. Image Registration : SPECT/CT Post-registration SPECT/CTs: • Sequential Rigid & Deformable • Elastix* (ITK-based, adjustable parameters, scriptable) • Multi-resolution B-Spline Deformation • Mutual Information Metric (80%) + deformation penalty (20%) • Robust, few ‘optical flow’-type artifacts • Co-register Anatomical (CT) volumes • Warp functional (SPECT) images • Inspect registered SPECTs • Apply translation where necessary • Output: 3 SPECT volumes aligned to 4- hour CT (fixed image) array space • Same resolution & origin (Image Position Patient 4-hour 24-Hour Difference/Overlay * Klein, S., Staring, M. & Pluim, J.P.W., 2007. Evaluation of optimization methods for nonrigid medical image registration using mutual information and B-splines. IEEE transactions on image processing : a publication of the IEEE Signal Processing Society, 16(12), pp.2879-90. 4-hour: Red 24-hour: Green

  7. Aligned Images  Voxelized Kinetics 72 Hr SPECT 24 Hr SPECT 4 Hr SPECT • 3 Co-registered SPECT Series  1 Volume (cumulated activity) • Read Time P.I. From DICOM header • Decay-correct activity values • Voxel-by-voxel • Analytical fit of 3-phase exponential pharmacokinetics • 1 Uptake, 2 Clearance • -A1=A2+A3 (C=0 at t=0) • K1>k2>k3 • Ignore values ~0 (out of patient or not relevant for dosimetry) • Adjust unrealistic, noisy values • Calculate for slope (as exponential) between measurements • Solve k3, A3 • Solve k2, A2 • Solve k1 • Limit Rate constants (k) to realistic range where necessary • Weighted for final time point • Single-threaded, but efficient (50-100x improvement over iterative curve-fitting routine: Scipy.Optimize) • 25M Voxels/Hr • 2-Position Chest/Abdo SPECT: 1.5 Hours Cumulated Activity

  8. Kinetics Processing • 3x SPECT Array of kinetics parameters (A1, k1, A2, k2, A3, k3): [x,y,z,6] • Integrate decay-adjusted curves for disintegrations per unit volume • Output: Cumulated Activity (Bq*Hrs)/(mL) • Save as dicom (.dcm) or ITK (.mhd/.raw) file • Visual Output • Can be use to create image sequence of uptake & clearance • Arguments: slice #,projection (axial, sagittal, coronal), time window, # of frames • Save frames at times t • Interpolated Activity • Interpolated cumulated activity • Informative evaluation of relative uptake & clearance • Contribution of activity at time t to total # of disintegrations Activity t=0-100Hrs Cumulated Activity (Bq/mL) (Bq*Hr/mL)

  9. Dose Calculation Point Spread Function EDKnrc Sphere Model Cumulated Activity  Absorbed Dose • EGSnrc Simulation for beta- andphoton components of 177LuDecay • All tissue assumed to be H2O equivalent • Voxel S-Values for beta- component • Local energy deposition (only voxel self-dose) • Agreement with publishedS-values* • Long-range Gamma Voxel Dose Kernel • Low-resolution (high-efficiency) • 1.6*1.6*2.0 cm Voxels • Kernel calculated by dosxyz (EGSnrc) • Convolved through activity array VSV Calculation dosxyz (EGSnrc) *Lanconelli, N. et al., 2012. A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions. Physics in medicine and biology, 57(2), pp.517-33.

  10. Beta- Range vs. SPECT Resolution Range of beta electron transport shorter than range of SPECT Partial Volume effect SPECT Partial Volume effect for point source: Gaussian spread w/FWHM 7-15 mm* Absorbed Dose range for 177Lu beta-: 1-2 mm Activity heterogeneity clearly evident in PET \ Beta- energy from apparent activity (as seen on SPECT) considered to be deposited locally (in same voxel) 68Ga-Octreotate PET Imaging 1.1 Hrs PI * Gear, J. et al., 2011. Monte Carlo verification of polymer gel dosimetry applied to radionuclide therapy: a phantom study. Physics in Medicine and Biology, 56, p.7273. 177Lu-Octreotate SPECT Imaging 24 Hrs PI

  11. Gamma Dose Convolved Cumulated Activity Array Gamma Kernel (dosxyz) • Small proportion of total dose • ~5-20% depending on region • Greater Range • Soft dose gradient • Dose Kernel from DOSxyz • Low-resolution (voxels 1.6*1.6*2.0 cm3) • Long range (21 cm max) • In processing: • Convolve through activity array • Combine with beta component for total absorbed dose • Output can be written as dose volume from beta-, gamma, combined • maintains alignment to CT data Gamma dose (13%) Beta- dose (87%)

  12. Validation Methods • Coregister Serial SPECT/CT Volumes • Segment fixed CT volume in each study • Lower Large Intestine, Small intestine, Stomach, Upper Large Intestine, Heart , Kidneys, Liver, Lungs, Muscle, Pancreas, Marrow, Spleen, Bladder, Lesion • OLINDA Analysis • Apply segmentation to serial SPECT scans • Input mean organ activity values • Compute mean organ dose • VRAK Analysis • Apply segmentation to dose volume • Report Mean organ dose

  13. Results: Cumulated Activity & Organ Dose as compared to OLINDA *Compartmental Organs in MIRD model (separate source & target regions; contents + wall) At Riskorgans (Somatostatin Analog PRRT)

  14. Results: Cumulated Activity & Organ Dose as compared to OLINDA • Estimate of decays and total dose to kidneys, liver & spleen in the range of 5% with respect to conventional technique • Segmenting both contents and wall of compartmental organs overestimates dose by 30-100% • Greatest discrepancy in bladder • Similar effect observed in marrow • Comparable estimate of cumulated activity, but higher dose in segmented volume • Geometric effect accounted for by organ S-Value • Selective segmentation required • But susceptible to partial volume effect Compartmental Organ Model Source Volume Tissue (Bladder Wall) MIRD Bladder: Ellipsoid Source (Radius x,y,z: 4.71, 3.21, 3.21 cm) Outer Wall (Tissue) 2.5 mm thickness

  15. Results: Organ S-Value • VRAK beta- VSV + gamma kernel closely matches MIRD S-values for solid organs • Common at risk organs in PRRT • Lesions are solid volumes too • Mean Lesion Dose (between all studies): 24.5 ± 9.7 Gy • ~10:1 ratio lesion to kidney dose (10.1±6.0) • Fraction of total patient dose from beta- emission: 87.1±0.75% • MIRD model better suited to compartmental organs • But MIRD schema does not account for self-dose to GI wall, only from contents • Relevant in somatostatin analog therapy

  16. HU mGy 4-Hour CT VRAK Dose Discussion • Efficient, automated tool for PRRT dosimetry using serial functional images • Close agreement with OLINDA in both kinetics and dose estimates at organ level for 177Lu-octreotate dataset • Smooth, predictable kinetics estimation • No artifacts or noise from processing • Visually clear dosimetry data that can be overlaid with CT volume • Non-specific in design: can be applied to other isotopes, quantitative imaging (PET) • Need to know: physical half-life, isotope VSV & Gamma Kernel (dosxyz) • Personalized dosimetry data from initial cycle may be used to inform subsequent therapies • Radionuclide dosage • Extended renal-protective measures • Monitor relevant biochemical markers for at-risk organs

  17. Discussion • Limitations: • Homogenous tissue (H2O) assumed • Resolution of SPECT (1-2 cm) • Detection of highly heterogeneous uptake? • Disintegrations in tumour spread across larger volume • Reduces estimate of absorbed dose in lesion • Registration accuracy varies • In range of 5 mm for most organs • Other algorithms (Demons, etc) can be more precise, but prone to artifacts • Inconsistent breath hold can shift activity near diaphragm (liver & metastases, spleen) • Kinetics Fitting may overestimate cumulated activity to organs with transient uptake at early time point (bladder, bowel) • Not observed in critical organs, tumour volumes Anatomical Volume Approx. Margin of SPECT volume

  18. Project Homepage • VRAK: http://code.google.com/p/vrak-dosimetry/ • Dependencies: • Elastix (http://elastix.isi.uu.nl/about.php) • Python 2.7 (http://www.python.org/download/releases/2.7.3/) • Pydicom (0.9.7) (http://code.google.com/p/pydicom/downloads/list) • Numpy (1.6.2) (http://sourceforge.net/projects/numpy/files/) • For Video: • ffmpeg (compiled from source) (http://ffmpeg.org/download.html) • PIL (http://www.pythonware.com/products/pil/) • Matplotlib (1.1.1) (http://sourceforge.net/projects/matplotlib/files/matplotlib/matplotlib-1.1.1/) • Recommended Viewer: 3D Slicer (http://www.slicer.org/)

  19. References • Beauregard, J.-M. et al., 2011. Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system. Cancer imaging: the official publication of the International Cancer Imaging Society, 11, pp.56-66. • Lanconelli, N. et al., 2012. A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions. Physics in medicine and biology, 57(2), pp.517-33. • ICRP, 1983. Radionuclide Transformations: Energy and Intensity of Emissions. In ICRP Publication 38. Pergamon Press. • Kawrakow, I. & Walters, B.R.B., 2006. Efficient photon beam dose calculations using DOSXYZnrc with BEAMnrc. Medical Physics, 33(8), p.3046. • Klein, S., Staring, M. & Pluim, J.P.W., 2007. Evaluation of optimization methods for nonrigid medical image registration using mutual information and B-splines. IEEE transactions on image processing: a publication of the IEEE Signal Processing Society, 16(12), pp.2879-90. • Stabin, M.G., Sparks, R.B. & Crowe, E., 2005. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 46(6), pp.1023-7. • Gear, J. et al., 2011. Monte Carlo verification of polymer gel dosimetry applied to radionuclide therapy: a phantom study. Physics in Medicine and Biology, 56, p.7273. • Eckerman, K. et al., 1994. Availability of nuclear decay data in electronic form, including beta spectra not previously published. Health physics, 67(4), pp.338-345.

More Related